-
EP2244742
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2244742
| EP2244742 - THERAPY SELECTION METHOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.01.2015 Database last updated on 19.10.2024 | Most recent event Tooltip | 09.01.2015 | Application deemed to be withdrawn | published on 11.02.2015 [2015/07] | Applicant(s) | For all designated states GE Healthcare AS Nycoveien 1-2 P.O. Box 4220 0401 Nydalen / NO | [2010/44] | Inventor(s) | 01 /
DANIKAS, Antonios GE Healthcare Limited The Grove Centre White Lion Road Amersham Buckinghamshire HP7 9LL / GB | 02 /
SMITH, Clifford GE Healthcare Limited The Grove Centre White Lion Road Amersham Buckinghamshire HP7 9LL / GB | 03 /
WILSON, Ian A GE Healthcare Limited The Grove Centre White Lion Road Amersham Buckinghamshire HP7 9LL / GB | [2010/44] | Representative(s) | Bannan, Sally, et al GE Healthcare Limited Intellectual Property Pollards Wood Nightingales Lane Chalfont St.Giles Buckinghamshire HP8 4SP / GB | [N/P] |
| Former [2010/44] | Canning, Lewis R., et al GE Healthcare Limited Pollards Wood Nightingales Lane Chalfont St Giles Buckinghamshire HP8 4SP / GB | Application number, filing date | 09714806.8 | 26.02.2009 | [2010/44] | WO2009EP52282 | Priority number, date | GB20080003477 | 26.02.2008 Original published format: GB 0803477 | [2010/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009106566 | Date: | 03.09.2009 | Language: | EN | [2009/36] | Type: | A2 Application without search report | No.: | EP2244742 | Date: | 03.11.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.09.2009 takes the place of the publication of the European patent application. | [2010/44] | Search report(s) | International search report - published on: | EP | 10.12.2009 | Classification | IPC: | A61K49/00, A61K51/00, A61P35/00 | [2010/44] | CPC: |
A61K49/0032 (EP,US);
A61K49/0056 (EP,US);
A61K51/0446 (EP,US);
A61K51/0453 (EP,US);
A61K51/0455 (EP,US);
A61P35/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/44] | Title | German: | THERAPIEAUSWAHLVERFAHREN | [2010/44] | English: | THERAPY SELECTION METHOD | [2010/44] | French: | PROCÉDÉ DE SÉLECTION D'UNE THÉRAPIE | [2010/44] | Entry into regional phase | 18.08.2010 | National basic fee paid | 18.08.2010 | Designation fee(s) paid | 18.08.2010 | Examination fee paid | Examination procedure | 18.08.2010 | Examination requested [2010/44] | 03.11.2010 | Amendment by applicant (claims and/or description) | 08.01.2013 | Despatch of a communication from the examining division (Time limit: M06) | 04.07.2013 | Reply to a communication from the examining division | 03.09.2014 | Application deemed to be withdrawn, date of legal effect [2015/07] | 29.09.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2015/07] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 08.01.2013 | Fees paid | Renewal fee | 23.02.2011 | Renewal fee patent year 03 | 24.02.2012 | Renewal fee patent year 04 | 27.02.2013 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 28.02.2014 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DY]WO2005058371 (AMERSHAM HEALTH AS [NO], et al) [DY] 1-16 * Claims. Abstract, page 24-26 *; | [A]WO02087630 (EUROSPITAL S P A [IT], et al) [A] 1-16 * Claims *; | [DY] - SAFRAN H. ET AL., "Trastazumab, Paclitaxel , Cisplatin, and Radiation for Adenoicarcinoma of the Esophagus: A Phase I study", CANCER INVESTIGATION, (2004), vol. 22, no. 5, pages 670 - 677, XP008113486 [DY] 1-16 * Abstract, page 672 first paragraph, page 673 second paragraph. * DOI: http://dx.doi.org/10.1081/CNV-200032951 | [DA] - KIESSLICH ET AL, "In Vivo Histology of Barrett's Esophagus and Associated Neoplasia by Confocal Laser Endomicroscopy", CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, AMERICAN GASTROENTEROLOGICAL ASSOCIATION, US, (20060801), vol. 4, no. 8, ISSN 1542-3565, pages 979 - 987, XP005581169 [DA] 1-16 DOI: http://dx.doi.org/10.1016/j.cgh.2006.05.010 | [DA] - WALDMANN S. A., "Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells", FUTURE MEDICINE, (2006), vol. 2, no. 6, pages 705 - 716, XP008113480 [DA] 1-16 DOI: http://dx.doi.org/10.2217/14796694.2.6.705 | [DA] - WATSON G A ET AL, "Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma", NEOPLASIA, NEOPLASIA PRESS, ANN ARBOR, MI, US, (20061101), vol. 8, no. 11, ISSN 1522-8002, pages 949 - 955, XP008113475 [DA] 1-16 DOI: http://dx.doi.org/10.1593/neo.06499 | [DA] - MARTINS A. S. ET AL., "insuline-Like Growth Factor i Receptor Pathway Inhibition by ADW742, Alone or in combination with Imatinib, Doxorubicin, or Vincristine, Is a Novel Therapeutic Approach in Ewing Tumor", CLIN CANCER RES, (2006), vol. 12, no. 11, pages 3532 - 3540, XP002551195 [DA] 1-16 * abstract * DOI: http://dx.doi.org/10.1158/1078-0432.CCR-05-1778 |